Benefits and challenges of early introduction of left ventricular assist device placement a patient-centered perspective

Journal of the American College of Cardiology

Volumn 66, Issue 16, 2015, Pages 1762-1765

  Bruce, Courtenay R ^a   Blumenthal Barby, Jennifer S ^a   Meyers, Deborah ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Functional status; HeartMate II; quality of life; risk benefit analysis; ROADMAP

Indexed keywords

AWARENESS; CARDIOGENIC SHOCK; CARDIOLOGIST; CARDIOVASCULAR MORTALITY; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE SEVERITY; EARLY INTERVENTION; HEART FAILURE; HUMAN; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; MEDICAL INFORMATION; MEDICAL LITERATURE; NEW YORK HEART ASSOCIATION CLASS; NOTE; PATIENT CODING; PATIENT DECISION MAKING; PATIENT EDUCATION; PATIENT REFERRAL; PATIENT SELECTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TIME TO TREATMENT; FEMALE; HEART ASSIST DEVICE; MALE;

FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE;

EID: 84944112008     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.08.852     Document Type: Editorial

References (13)

1. O.H. Frazier, E.A. Rose, M.C. Oz, and et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation J Thorac Cardiovasc Surg 122 2001 1186 1195
2. E.A. Rose, A.C. Gelijns, A.J. Moskowitz, and et al. Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
3. M.S. Slaughter, J.G. Rogers, C.A. Milano, and et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
4. F.D. Pagani, L.W. Miller, S.D. Russell, and et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
5. K.D. Aaronson, M.S. Slaughter, L.W. Miller, and et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
6. J.D. Estep, R.C. Starling, D.A. Horstmanshof, and et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study J Am Coll Cardiol 66 2015 1747 1761
7. J.S. Blumenthal-Barby, K.M. Kostick, E.D. Delgado, and et al. Assessment of patients' and caregivers' informational and decisional needs for left ventricular assist device placement: implications for informed consent and shared decision-making J Heart Lung Transplant 34 2015 1182 1189
8. A.J. Boyle, D.D. Ascheim, M.J. Russo, and et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification J Heart Lung Transplant 30 2011 402 407
9. C.K. McIlvennan, L.A. Allen, C. Nowels, and et al. Decision making for destination therapy left ventricular assist devices: "there was no choice" versus "I thought about it an awful lot." Circ Cardiovasc Qual Outcomes 7 2014 374 380
10. A.L. Ottenberg, K.E. Cook, R.J. Topazian, and et al. Choices for patients "without a choice": interviews with patients who received a left ventricular assist device as destination therapy Circ Cardiovasc Qual Outcomes 7 2014 368 373
11. C.R. Bruce, K.M. Kostick, E.D. Delgado, and et al. Reasons why eligible candidates decline left ventricular assist device placement J Card Fail 2015 Jun 22 [E-pub ahead of print]
12. L.A. Allen, J.E. Yager, M.J. Funk, and et al. Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure JAMA 299 2008 2533 2542
13. U.S. Food and Drug Administration. Serious adverse events with implantable left ventricular assist devices (LVADs): FDA safety communication. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm457327.htm. Accessed August 6, 2015.